
The European Commission is considering proposals that would allow EU member States to help companies through the injection of equity, the latest move aimed at relaxing State aid rules to tackle the coronavirus crisis, reported the Financial Times.
The new proposal calls on member States to “provide further support in equity or hybrid capital instruments” to those businesses directly affected by the pandemic, people with direct knowledge of the plan said.
Under the scheme, the granting of financial support would be conditional on companies meeting certain standards of good governance and giving commitments on how they would use the aid.
The proposal is still being drafted, but it may be announced later this week. Member States could approve the new measures shortly thereafter, though people close to the process said the timing could slip and that discussions were still ongoing.
The EU’s State aid rules restrict how member States can recapitalise companies. “Their investments are either on strict market terms or count as aid with stringent conditions, including requiring companies to shrink and restructure their businesses,” said James Webber, a partner at Shearman & Sterling in London.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas